Unsung immune cells take over when covid antibodies wane
Antibodies have become a familiar word in the pandemic era, perhaps suggesting they’re the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released…
At about ₹1,500 per shot of covid vaccine, US sets global pricing benchmark
The US government has set a benchmark for COVID-19 vaccine pricing in a $2 billion deal announced on Wednesday with Pfizer Inc and German biotech BioNTech SE that will likely…
Low chance of covid vaccine this year, Boris Johnson’s medical adviser says
Chris Whitty, UK Prime Minister Boris Johnson’s senior medical adviser, said there is only a slim chance of an effective coronavirus vaccine being available by Christmas, even as the University…
Britain orders 9 crore doses of coronavirus vaccine
Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer Inc and BioNTech alliance and French group Valneva, Reuters reported. It said Britain…
BioNTech, Pfizer covid vaccine expected to be ready for approval by year end
BENGALURU : BioNTech SE and Pfizer Inc’s coronavirus vaccine candidate is expected to be ready to seek regulatory approval by the end of 2020, the Wall Street Journal reported on…